These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8341148)

  • 1. Economic evaluation of a Ninngen-dokku (medical checkup).
    Shimizu T; Suzuki T
    Methods Inf Med; 1993 Apr; 32(3):199-202. PubMed ID: 8341148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Checkup interval and cancers in automated multiphasic health testing and services.
    Hinohara S; Takahashi T; Uemura H; Noto T; Shinozuka T; Kinoshita H; Matsuyama M; Suzuki S; Osamura Y; Oogushi Y
    Methods Inf Med; 1993 Apr; 32(3):192-4. PubMed ID: 8341146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Screening for colorectal carcinoma in AMHTS (automated multiphasic health testing and services)].
    Kikkawa N; Sasai H; Murai M; Mizuno S; Miyagawa S; Furota A
    Gan No Rinsho; 1983 Nov; 29(14):1644-6. PubMed ID: 6663710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of mobile cancer screening and prevention.
    O'Malley AS; Lawrence W; Liang W; Yabroff R; Lynn J; Kerner J; Mandelblatt J
    J Health Care Poor Underserved; 2002 Aug; 13(3):298-319. PubMed ID: 12152502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National statistics on multiphasic health testing (human dock and AMHTS)--especially for the annual-course change during the last five years.
    Sasamori N
    Jpn Hosp; 1990 Jul; 9():83-95. PubMed ID: 10108047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of health checkups--an illustrative study.
    Collen MF
    West J Med; 1984 Dec; 141(6):786-92. PubMed ID: 6441347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Check-up studies at an internal medicine polyclinic: reasons, diagnostic tests, results and therapeutic consequences].
    Osterwalder P; Steurer J
    Praxis (Bern 1994); 1998 Dec; 87(50):1735-40. PubMed ID: 9889585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivering affordable cancer care in high-income countries.
    Sullivan R; Peppercorn J; Sikora K; Zalcberg J; Meropol NJ; Amir E; Khayat D; Boyle P; Autier P; Tannock IF; Fojo T; Siderov J; Williamson S; Camporesi S; McVie JG; Purushotham AD; Naredi P; Eggermont A; Brennan MF; Steinberg ML; De Ridder M; McCloskey SA; Verellen D; Roberts T; Storme G; Hicks RJ; Ell PJ; Hirsch BR; Carbone DP; Schulman KA; Catchpole P; Taylor D; Geissler J; Brinker NG; Meltzer D; Kerr D; Aapro M
    Lancet Oncol; 2011 Sep; 12(10):933-80. PubMed ID: 21958503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of multiphasic screening: old controversies and a new rationale.
    Werner M; Altshuler CH
    Hum Pathol; 1981 Feb; 12(2):111-7. PubMed ID: 6783505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A medical algorithm for detecting physical disease in psychiatric patients.
    Sox HC; Koran LM; Sox CH; Marton KI; Dugger F; Smith T
    Hosp Community Psychiatry; 1989 Dec; 40(12):1270-6. PubMed ID: 2512242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of screening-detected prostate cancer on health checkup].
    Uchida K; Akaza H
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1527-32. PubMed ID: 9725044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cancer and health economics].
    Koinuma N
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):1-7. PubMed ID: 8546457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of intensive chemotherapy with prophylactic granulocyte colony-stimulating factor for patients with high-risk early breast cancer in Japan.
    Ishiguro H; Kondo M; Hoshi SL; Takada M; Nakamura S; Teramukai S; Yanagihara K; Toi M
    Clin Ther; 2010 Feb; 32(2):311-26. PubMed ID: 20206789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost and technology: the case for preventive medicine.
    Collen MF
    Clin Eng; 1978 Dec; 6(6):65-8. PubMed ID: 10308793
    [No Abstract]   [Full Text] [Related]  

  • 16. The futility and lack of cost-effectiveness in screening for cancer.
    Handler S
    Minn Med; 1992 Dec; 75(12):13-6. PubMed ID: 1470083
    [No Abstract]   [Full Text] [Related]  

  • 17. [From the Point of View of Health Evaluation and Promotion (Ningen Dock) Facilities].
    Yamashita T; Funatsu K; Kondo S; Yokoyama M; Mizuno K; Nakamura H
    Rinsho Byori; 2014 Sep; 62(9):892-4. PubMed ID: 27526535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive procedures and screening: balancing the benefits.
    Lawrence M
    Practitioner; 1987 Dec; 231(1440):1651-4. PubMed ID: 3146060
    [No Abstract]   [Full Text] [Related]  

  • 19. Three year study on the assessment of EPSDT practices and cost.
    J Medicaid Manage; 1977; 1(4):55-8. PubMed ID: 10308915
    [No Abstract]   [Full Text] [Related]  

  • 20. [Economic criteria in assessing the efficacy of the fight against cancer].
    Diatchenko OT; Shabashova NIa
    Vopr Onkol; 1988; 34(12):1411-21. PubMed ID: 3146159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.